Information about the production facility in which APIs are manufactured for medicinal products
Level: Spearhead
The purpose of this award criterion is to increase transparency and traceability when active pharmaceutical ingredients (APIs) are manufactured. Information provided on where APIs are manufactured for the medicinal products covered by the agreement allows contracting authorities to better identify environmental and social risks, and to prioritise follow-up efforts.
Details
- Type:
- Award criteria
- ID:
- 11370
- Group:
- Medicinal Products
Criterion text
In order to receive [points or discounts per position], the supplier must provide information regarding where (name(s) and accompanying address(es) of production facility) active pharmaceutical ingredients (APIs) are manufactured for the medicinal products that are offered.
If this award criterion is met, the supplier must, without delay during the contract period, notify of any changes with regards to where (name(s) and address(es) of production facility) APIs are manufactured for the medicinal products for which the supplier has provided information.
Verification
In order to receive [points or discounts per position] in the tender evaluation, the supplier must provide information together with its tender regarding where (name(s) and address(es) of production facility) the APIs are manufactured for the medicinal products that are offered. The source of the information or where it can be accessed can vary depending on the supplier's business model or trading situation.
Proposed follow-up
Ensure that the contractual terms describe how the follow-up process will be carried out, and which documentation or information the supplier needs to submit and when.
When following up, the contracting authority may request the supplier to provide supporting information regarding where APIs for contracted medicinal products are manufactured. For more information, see the implementation manual.
Subject matter of contract
Procurement object. Medicinal products for Inpatient care.
Information about the criterion
This award criterion can be applied separately or together with the following additional award criteria:
· Information on the location of pharmaceutical formulation (Requirement ID 11223, advanced level)
· Information on the location of API production for medicinal products (Requirement ID 11225, advanced level)
· Information about the production facility in which pharmaceutical formulation takes place (Requirement ID 11369, spearhead level)
A medicinal product may be manufactured at more than one geographical location. A supplier may therefore need to provide information about several production facilities, together with their addresses, where APIs are manufactured for the medicinal products that are offered.
The contracting authority may check the provided details during the evaluation of tenders. For more information, see the implementation manual.
Versions history
The version date indicates when the sustainability criterion was created or last updated. Last reviewed dated tells when we last checked that the sustainability criterion still is relevant.
- Current ID
- 11370
- Version date
- 2019-10-23